Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey L Bennett

Showing results (1-10 of 191) with videos related to

Pageof 20
Sort By:
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|December 5, 2002
Developmental neurogenetics and neuro-ophthalmologyJeffrey L Bennett
Continuum (Minneapolis, Minn.)|October 5, 2019
Optic NeuritisJeffrey L Bennett
Neurological Research|May 12, 2006
Natalizumab and progressive multifocal leukoencephalopathy: migrating towards safe adhesion molecule therapy in multiple sclerosisJeffrey L Bennett
Neurology|July 17, 2023
Optical Coherence Tomography, Retinal Atrophy, and Neurodegeneration in Progressive Multiple Sclerosis: Sprinting to the FinishJeffrey L Bennett
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|August 17, 2016
Finding NMO: The Evolving Diagnostic Criteria of Neuromyelitis OpticaJeffrey L Bennett
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|August 15, 2018
Acute Management of Optic Neuritis: An Evolving ParadigmLindsay Horton, Jeffrey L Bennett
CNS Drug Reviews|April 28, 2007
Pharmacological properties, toxicology and scientific rationale for the use of natalizumab (Tysabri) in inflammatory diseasesOlaf Stüve, Jeffrey L Bennett
International Review of Neurobiology|May 29, 2007
Optic neuritis and the neuro-ophthalmology of multiple sclerosisParamjit Kaur, Jeffrey L Bennett
Clinical Neuropharmacology|June 2, 2009
Update on inflammation, neurodegeneration, and immunoregulation in multiple sclerosis: therapeutic implicationsJeffrey L Bennett, Olaf Stüve
Annals of Neurology|April 24, 2012
Cerebrospinal fluid proteomics: a new window for understanding human demyelinating disorders?Jeffrey L Bennett, Gregory P Owens
Pageof 20

Showing results (1-10 of 191) with videos related to

Sort By:
Pageof 20
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|December 5, 2002
Developmental neurogenetics and neuro-ophthalmologyJeffrey L Bennett
Continuum (Minneapolis, Minn.)|October 5, 2019
Optic NeuritisJeffrey L Bennett
Neurological Research|May 12, 2006
Natalizumab and progressive multifocal leukoencephalopathy: migrating towards safe adhesion molecule therapy in multiple sclerosisJeffrey L Bennett
Neurology|July 17, 2023
Optical Coherence Tomography, Retinal Atrophy, and Neurodegeneration in Progressive Multiple Sclerosis: Sprinting to the FinishJeffrey L Bennett
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|August 17, 2016
Finding NMO: The Evolving Diagnostic Criteria of Neuromyelitis OpticaJeffrey L Bennett
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|August 15, 2018
Acute Management of Optic Neuritis: An Evolving ParadigmLindsay Horton, Jeffrey L Bennett
CNS Drug Reviews|April 28, 2007
Pharmacological properties, toxicology and scientific rationale for the use of natalizumab (Tysabri) in inflammatory diseasesOlaf Stüve, Jeffrey L Bennett
International Review of Neurobiology|May 29, 2007
Optic neuritis and the neuro-ophthalmology of multiple sclerosisParamjit Kaur, Jeffrey L Bennett
Clinical Neuropharmacology|June 2, 2009
Update on inflammation, neurodegeneration, and immunoregulation in multiple sclerosis: therapeutic implicationsJeffrey L Bennett, Olaf Stüve
Annals of Neurology|April 24, 2012
Cerebrospinal fluid proteomics: a new window for understanding human demyelinating disorders?Jeffrey L Bennett, Gregory P Owens
Pageof 20